Interventional Radiology Imaging

Should You Request TIPS for a Cirrhotic Patient with Refractory Variceal Bleeding and MELD 13?

·
Should You Request TIPS for a Cirrhotic Patient with Refractory Variceal Bleeding and MELD 13?

A 58-year-old male with known alcohol-related cirrhosis is admitted with hematemesis. Endoscopy reveals active bleeding from both esophageal and gastric varices, and attempts at sclerotherapy and banding are unsuccessful in achieving hemostasis. His Model for End-Stage Liver Disease (MELD) score is 13, and a recent CT scan of the abdomen shows a small, non-dominant gastrorenal shunt. A hepatic venous pressure gradient (HVPG) measurement confirms significant portal hypertension at 22 mmHg. The gastroenterology team is asking for interventional radiology consultation for definitive management. This specific clinical crossroads—endoscopic failure in a patient with moderately preserved liver function—requires a clear understanding of the next best step. For this presentation, the American College of Radiology (ACR) Appropriateness Criteria rate a Transjugular Intrahepatic Portosystemic Shunt (TIPS) as Usually appropriate.

Who Fits This Clinical Scenario?

This guidance applies to a specific subset of patients with decompensated cirrhosis. The key inclusion criteria are active or recent bleeding from both esophageal and gastric varices that has proven refractory to endoscopic management. The patient’s liver function is moderately preserved, as indicated by a MELD score of 13, placing them in an intermediate-risk category. Furthermore, the hemodynamic profile is defined by significant portal hypertension (hepatic wedge pressure of 22 mmHg, well above the clinically significant threshold of 10 mmHg) and the presence of a small gastrorenal shunt on cross-sectional imaging.

This workflow is distinct from several similar presentations. This guidance does not apply to patients with:

  • A large, high-flow gastrorenal shunt: In patients with a dominant shunt, particularly with isolated gastric varices, Balloon-occluded Retrograde Transvenous Obliteration (BRTO) becomes a more viable option.
  • Severe hepatic encephalopathy: For patients with pre-existing, poorly controlled encephalopathy, a TIPS procedure may be contraindicated or require careful consideration of shunt diameter, as it can significantly worsen this condition.
  • A very high MELD score (e.g., >20): In patients with advanced liver failure, the mortality risk associated with a TIPS procedure increases substantially, and the decision-making process becomes more complex, often favoring liver transplantation evaluation as the primary goal.
  • Gastric variceal bleeding from splenic vein occlusion: This condition, often seen in pancreatitis, represents a different pathophysiology (sinistral or “left-sided” portal hypertension) and is managed differently, often with splenectomy or splenic artery embolization, not TIPS.

What Is the Underlying Problem We Are Addressing?

In this scenario, the primary diagnosis of bleeding gastroesophageal varices is already established. The interventional workup focuses on addressing the underlying hemodynamic cause that has made the condition refractory to standard endoscopic therapy. The key problem is severe portal hypertension, which creates a high-pressure gradient that endoscopic measures like banding cannot overcome long-term.

The presence of both esophageal and gastric varices signifies widespread portosystemic collateral formation. This is not a localized problem that can be managed by targeting a single varix or a single shunt. The goal of intervention must be to globally reduce the pressure within the entire portal venous system. The finding of a small gastrorenal shunt is a critical piece of information; it indicates that the body’s attempt to decompress the portal system via this pathway is insufficient to prevent variceal formation and bleeding.

Therefore, the therapeutic goal is not simply to obliterate the bleeding varices but to create a durable, low-resistance outflow for portal blood. This directly addresses the high portal pressure that is driving the formation and rupture of both sets of varices, providing a more definitive solution than localized, obliterative techniques.

Why Is TIPS Usually Appropriate for This Presentation?

The ACR designates a Transjugular Intrahepatic Portosystemic Shunt (TIPS) as Usually appropriate because it directly and effectively treats the root cause of the bleeding: severe portal hypertension. By creating a low-resistance channel between the portal vein and a hepatic vein, TIPS diverts a significant portion of portal blood flow away from the varices and into the systemic circulation. This global decompression of the portal system is highly effective at controlling bleeding from both esophageal and gastric varices simultaneously, which is essential in this patient’s case.

The patient’s MELD score of 13 and HVPG of 22 mmHg make them an ideal candidate. The MELD score is low enough that the risk of post-TIPS liver failure is acceptable, yet the portal pressure is high enough to indicate a clear need for decompression. TIPS has a high technical success rate and is highly effective at preventing variceal re-bleeding.

Alternative procedures are rated lower for specific reasons in this context:

  • BRTO is rated Usually not appropriate. While BRTO is an excellent option for isolated gastric varices fed by a large gastrorenal shunt, it is the wrong choice here. Attempting BRTO through a small shunt would be technically difficult. More importantly, occluding the shunt would block a portal outflow path, potentially increasing portal pressure and worsening the bleeding from the esophageal varices.
  • Surgical management (e.g., surgical shunts) is rated May be appropriate. Surgical shunts are also effective at decompressing the portal system but are associated with significantly higher procedural morbidity and mortality compared to the minimally invasive TIPS procedure. For a patient with a MELD of 13, TIPS is the preferred first-line decompressive therapy.
  • Partial splenic embolization is rated May be appropriate. This procedure reduces portal inflow by decreasing blood flow from the spleen. While it can lower portal pressure, it is generally less effective than TIPS for acute control of refractory bleeding and is more often used as an adjunct or for managing thrombocytopenia.

TIPS is performed under fluoroscopic guidance, which involves ionizing radiation. However, in the setting of life-threatening variceal hemorrhage, the benefit of achieving hemostasis far outweighs the radiation risk.

What’s Next After TIPS? Downstream Workflow

The post-procedure workflow focuses on monitoring for efficacy and managing potential complications. The immediate next step is to confirm clinical stability and cessation of bleeding. Patients are typically monitored in an intensive care or step-down unit for at least 24 hours.

  • If the TIPS is successful and bleeding stops: The patient can be transitioned to medical management, including non-selective beta-blockers and surveillance for hepatic encephalopathy. A baseline TIPS ultrasound is typically performed within 24-72 hours to establish post-procedure flow velocities. Routine ultrasound surveillance is then scheduled (e.g., at 1, 3, 6, and 12 months) to monitor for shunt stenosis, a common cause of late re-bleeding.
  • If bleeding continues or recurs shortly after TIPS: This suggests a technical issue. Urgent evaluation of the TIPS shunt is necessary, often with direct portography (TIPS venogram) to assess for shunt thrombosis, stenosis, or inadequate portal decompression. Revision of the TIPS, such as angioplasty or additional stent placement, may be required.
  • If the patient develops new or worsening hepatic encephalopathy: This is the most common complication of TIPS. First-line management is medical, with lactulose and rifaximin. If the encephalopathy is severe and refractory to medical therapy, it may be necessary to perform a TIPS reduction, where the shunt is intentionally narrowed to decrease the degree of portosystemic shunting.

A successful TIPS procedure serves as a crucial bridge, stabilizing the patient and allowing for consideration of the definitive treatment for their liver disease: liver transplantation evaluation.

Pitfalls to Avoid (and When to Get Help)

Navigating this clinical scenario requires avoiding several common pitfalls. First, do not misinterpret the small gastrorenal shunt as an indication for BRTO; in the presence of co-existing esophageal varices, BRTO is contraindicated as it can worsen portal hypertension. Second, do not underestimate the risk of hepatic encephalopathy, even with a moderate MELD score of 13; ensure the patient and family are counseled on this risk pre-procedure. Third, ensure a complete pre-procedural workup is performed, including recent cross-sectional imaging to map vascular anatomy and an echocardiogram to rule out severe right heart failure or pulmonary hypertension, which are relative contraindications to TIPS.

If the patient remains hemodynamically unstable despite initial resuscitation and endoscopic failure, this is a medical emergency. Escalate immediately by involving the interventional radiology team for emergent TIPS and consulting the transplant surgery and hepatology teams concurrently.

Related ACR Topics and Tools

This article covers a single, specific variant within the broader topic of managing gastric varices. For a comprehensive overview of all clinical scenarios and their corresponding ACR ratings, please consult our parent guide. For additional resources on imaging criteria, protocols, and radiation safety, the following tools are available.

Frequently Asked Questions

Why is BRTO ‘Usually not appropriate’ if the CT shows a gastrorenal shunt?

BRTO is not appropriate in this scenario for two main reasons. First, the shunt is described as small, which can make the procedure technically challenging or impossible. Second, and more critically, this patient is also bleeding from esophageal varices. BRTO works by occluding the gastrorenal shunt, which is an outflow path for the hypertensive portal system. Blocking this outflow can increase overall portal pressure, potentially worsening the esophageal varices and leading to more severe bleeding from that location.

What is the significance of the MELD score of 13 in choosing TIPS?

A MELD score of 13 indicates moderate liver dysfunction. It is high enough to warrant a definitive intervention for refractory bleeding but low enough that the patient is likely to tolerate the TIPS procedure without developing acute liver failure. The risk of post-TIPS mortality and hepatic encephalopathy increases significantly with higher MELD scores (typically >18-20), making the procedure much riskier in those patients. A score of 13 hits the ‘sweet spot’ where the benefits of portal decompression strongly outweigh the procedural risks.

How does the hepatic wedge pressure of 22 mmHg influence the choice of TIPS?

A hepatic venous pressure gradient (HVPG), or wedge pressure, of 22 mmHg confirms the presence of severe portal hypertension (clinically significant is >10 mmHg; risk of variceal bleeding increases substantially >12 mmHg). This high pressure is the direct cause of the variceal bleeding. The measurement confirms that a procedure designed to lower this pressure, like TIPS, is hemodynamically indicated and necessary to control the hemorrhage.

What are the main risks of TIPS I should discuss with the patient?

The two most significant risks to discuss are worsening hepatic encephalopathy and right heart failure. By shunting portal blood directly into the systemic circulation, TIPS bypasses the liver’s detoxification function, which can lead to a buildup of ammonia and other toxins, causing confusion or coma. The increased venous return to the heart can also strain the right ventricle, potentially causing heart failure in patients with pre-existing cardiac dysfunction. Other risks include bleeding, infection, and shunt stenosis or occlusion over time.

If TIPS is successful, what is the long-term management plan?

Long-term management involves regular surveillance of the TIPS shunt with Doppler ultrasound to ensure it remains patent, typically at 1, 3, 6, and 12 months post-procedure, and then annually. Patients also require ongoing medical management for their liver disease and any post-TIPS complications like hepatic encephalopathy. Importantly, TIPS is a bridge therapy, not a cure for cirrhosis. The patient should be referred for liver transplantation evaluation, as this is the only definitive treatment for end-stage liver disease.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026